Revised vs original QUICKI index during diet + rosiglitazone treatment in obese subjects [1]

Diabetes and Metabolism

Volumn 30, Issue 5, 2004, Pages 409-410

  Brunani, A ^a   Caumo, A ^b   Graci, S ^a   Margarini, C ^a   Viberti, G C ^c   Liuzzi, A ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID; ROSIGLITAZONE;

ADULT; BLOOD ANALYSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIET RESTRICTION; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; IMMUNOASSAY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LETTER; LIPID METABOLISM; LOW CALORY DIET; MALE; MEASUREMENT; METABOLIC PARAMETERS; METABOLIC RATE; OBESITY; PANCREAS ISLET BETA CELL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

EID: 10644225338     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70134-9     Document Type: Letter

References (8)

1. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in human. J Clin Endocrinol Metab, 2000, 85, 2402-10.
2. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab, 2001, 86, 4776-81.
3. Bastard JP, Jan V, Maachi M, et al. Incorporation of non esterified fatty acids into QUICKI is not relevant in obese subjects during diet induced weight loss. Diabetes Metab, 2002, 28, 333-4.
4. Oakes ND, Thalén PG, Jacinto SM, Ljung B. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes, 2001, 50, 1158-65.
5. Mayerson AB, Hundal RS, Dufour S, et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patient with type 2 diabetes. Diabetes, 2002, 51, 797-802.
6. Costacou T, Mayer-Davis EJ. Nutrition and prevention of type 2 diabetes. Annu Rev Nutr, 2003, 23, 147-70.
7. Virtanen KA, Hallsten K, Parkkola R, et al. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes, 2003, 52, 283-90.
8. Fisher RM, Hoffstedt J, Hotamisligil GS, Thorne A, Rydén M. Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue. Int J Obes Relat Metab Disord, 2002, 26, 1379-85.